Physician profile
Prachee Jain
NPI 1891878369
$890.67
in general payments reported to CMS, 2019-2025
12 companies · $44.70 in 2025
The $44.70 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.32 · 2020: $119 · 2021: $205 · 2022: $222 · 2023: $158 · 2024: $98.30 · 2025: $44.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.12 | 2021-2024 | |
| Lilly USA, LLC | $192.88 | 2020-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $135.94 | 2019-2025 | Airsupra, Farxiga |
| Allergan, INC. | $64.99 | 2019-2021 | |
| Abbott Laboratories | $42.58 | 2019-2025 | Eterna |
| Biohaven Pharmaceuticals, INC. | $37.22 | 2021 | |
| Pfizer INC. | $36.37 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $29.93 | 2022 | |
| Neuronetics, INC. | $27.86 | 2020 | |
| Boston Scientific Corporation | $19.56 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.08 | 2023 | |
| Idorsia Pharmaceuticals US INC | $15.14 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prachee Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.